SPRY CIK: 1671858

ARS Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−17.6
FY22:
−40.1
FY23:
−59.3
FY24:
13.5
FY25:
−171
Change from FY21 to FY25
millions USD
FY21:
−0.06
FY22:
−0.20
FY23:
−87.2
FY24:
−106
FY25:
56.8
Change from FY21 to FY25
millions USD
FY21:
53.2
FY22:
191
FY23:
6.90
FY24:
72.4
FY25:
105
millions USD
FY21:
35.5
FY22:
150
FY23:
−140
FY24:
−20.2
FY25:
−9.50
(positive)
Change from FY21 to FY25
millions USD
FY21:
−17.6
FY22:
−40.3
FY23:
−59.4
FY24:
13.0
FY25:
−171

All amounts in millions USD Data source:SEC EDGAR